Pamela Stephenson - 17 Feb 2026 Form 4 Insider Report for Disc Medicine, Inc. (IRON)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Feb 2026, 21:15:38 UTC
Prior SEC filing
11 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: /s/ Rahul Khara, as Attorney-in-Fact

Key filing fact

Pamela Stephenson filed Form 4 for Disc Medicine, Inc. (IRON) on 17 Feb 2026.

Key facts

  • This page summarizes Pamela Stephenson's Form 4 filing for Disc Medicine, Inc. (IRON).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Feb 2026, 21:15.

Change

  • Previous filing in this sequence was filed on 11 Feb 2026.
  • Current net transaction value: -$347,679.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001767650 Primary reporting owner

Stephenson Pamela

Relationship
Chief Commercial Officer
Address
C/O DISC MEDICINE, INC., 321 ARSENAL STREET, SUITE 101, WATERTOWN
Signature
By: /s/ Rahul Khara, as Attorney-in-Fact
Signature date
17 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRON transaction

Common Stock

Sale

Transaction value
$347,679
Shares
-5,531
Change %
-6.4%
Price
$62.86
Shares after
80,998
Date
17 Feb 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .